Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapyPin1 can drive the desmoplastic and immunosuppressive tumor microenvironment in addition to its known oncogenic functions.Pin1 can drive the desmoplastic and immunosuppressive tumor microenvironment in addition to its known oncogenic functions.Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu, Nobufumi Sekino, Nami Kim, Theresa D. Manz, Benika J. Pinch, Dipikaa Akshinthala, Ana Verma, Giorgio Gaglia, Yutaka Nezu, Shizhong Ke, Chenxi Qiu, Kenoki Ohuchida, Yoshinao Oda, Tae Ho Lee, Babara Wegiel, John G. Clohessy, Nir London, Sandro Santagata, Gerburg M. Wulf, Manuel Hidalgo, Senthil K. Muthuswamy, Masafumi Nakamura, Nathanael S. Gray, Xiao Zhen Zhou, Kun Ping Luhttps://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900879-5%3Frss%3Dyes&rc=0http://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignAugust 13, 2021
Powered by WPeMatico